Potential barriers to therapeutics utilizing pluripotent cell derivatives: Intrinsic immunogenicity of in vitro maintained and matured populations

Seminars in Immunopathology

Volumn 33, Issue 6, 2011, Pages 563-572

  Tang, Chad ^a   Drukker, Micha ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Embryonic stem cells; Immune modulation; Immunogenicity; Induced pluripotent stem cells; Pluripotent stem cells; Tissue regeneration

Indexed keywords

FETAL ANTIGEN; HLA E ANTIGEN; HLA G ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ALLOIMMUNITY; ANTIGEN EXPRESSION; CD4+ CD25+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CELL POPULATION; CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; HUMAN; IMMUNOCOMPETENCE; IMMUNOGENICITY; IMMUNOMODULATION; IMMUNOREACTIVITY; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; ISOGRAFT; LYMPHOCYTE FUNCTION; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; STEM CELL TRANSPLANTATION;

ANIMALS; ANTIGENS; CELL DIFFERENTIATION; CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; GRAFT REJECTION; HUMANS; IMMUNOMODULATION; IMMUNOSUPPRESSION; KILLER CELLS, NATURAL; PLURIPOTENT STEM CELLS; STAGE-SPECIFIC EMBRYONIC ANTIGENS; STEM CELL TRANSPLANTATION; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS;

EID: 81855194148     PISSN: 18632297     EISSN: 18632300     Source Type: Journal    
DOI: 10.1007/s00281-011-0269-5     Document Type: Review

References (88)

1. BJ Nankivell SI Alexander 2010 Rejection of the kidney allograft N Engl J Med 363 1451 1462 20925547 10.1056/NEJMra0902927 1:CAS:528:DC%2BC3cXhtlGksL3N
2. M Drukker G Katz A Urbach M Schuldiner G Markel, et al. 2002 Characterization of the expression of MHC proteins in human embryonic stem cells Proc Natl Acad Sci USA 99 9864 9869 12114532 10.1073/pnas.142298299 1:CAS:528:DC%2BD38XlslKgsLg%3D (Pubitemid 34831138)
3. WS Hwang YJ Ryu JH Park ES Park EG Lee, et al. 2004 Evidence of a pluripotent human embryonic stem cell line derived from a cloned blastocyst Science 303 1669 1674 14963337 10.1126/science.1094515 1:CAS:528: DC%2BD2cXhvFCntrw%3D (Pubitemid 38338325)
4. KJ McCreath J Howcroft KH Campbell A Colman AE Schnieke, et al. 2000 Production of gene-targeted sheep by nuclear transfer from cultured somatic cells Nature 405 1066 1069 10890449 10.1038/35016604 1:CAS:528: DC%2BD3cXkvFKku74%3D (Pubitemid 30447792)
5. K Takahashi K Tanabe M Ohnuki M Narita T Ichisaka, et al. 2007 Induction of pluripotent stem cells from adult human fibroblasts by defined factors Cell 131 861 872 18035408 10.1016/j.cell.2007.11.019 1:CAS:528:DC%2BD2sXhsVCntbbK (Pubitemid 350138099)
6. O Utermohlen N Baschuk Z Abdullah A Engelmann U Siebolts, et al. 2009 Immunologic hurdles of therapeutic stem cell transplantation Biol Chem 390 977 983 19642871 10.1515/BC.2009.114
7. M Drukker 2004 Immunogenicity of human embryonic stem cells: can we achieve tolerance? Springer Semin Immunopathol 26 201 213 15549307 10.1007/s00281-004-0163-5 (Pubitemid 40021967)
8. M Drukker N Benvenisty 2004 The immunogenicity of human embryonic stem-derived cells Trends Biotechnol 22 136 141 15036864 10.1016/j.tibtech.2004. 01.003 1:CAS:528:DC%2BD2cXhsV2nurg%3D (Pubitemid 38230392)
9. A Heiskanen T Satomaa S Tiitinen A Laitinen S Mannelin, et al. 2007 N-glycolylneuraminic acid xenoantigen contamination of human embryonic and mesenchymal stem cells is substantially reversible Stem Cells 25 197 202 17008421 10.1634/stemcells.2006-0444 1:CAS:528:DC%2BD2sXhvVGjtb4%3D (Pubitemid 46052991)
10. MJ Martin A Muotri F Gage A Varki 2005 Human embryonic stem cells express an immunogenic nonhuman sialic acid Nat Med 11 228 232 15685172 10.1038/nm1181 1:CAS:528:DC%2BD2MXpvF2msQ%3D%3D (Pubitemid 40321360)
11. TL Chung JP Turner N Thaker G Kolle JJ Cooper-White, et al. 2010 Ascorbate promotes epigenetic activation of CD30 in human embryonic stem cells Stem Cells 28 10 1782 1793 20715184 10.1002/stem.500 1:CAS:528: DC%2BC3cXhsFKntb3L
12. JS Draper K Smith P Gokhale HD Moore E Maltby, et al. 2004 Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells Nat Biotechnol 22 53 54 14661028 10.1038/nbt922 1:CAS:528:DC%2BD2cXls1eh (Pubitemid 38057956)
13. C Spits I Mateizel M Geens A Mertzanidou C Staessen, et al. 2008 Recurrent chromosomal abnormalities in human embryonic stem cells Nat Biotechnol 26 1361 1363 19029912 10.1038/nbt.1510 1:CAS:528:DC%2BD1cXhsVWjtL3M
14. N Fernandez J Cooper M Sprinks M AbdElrahman D Fiszer, et al. 1999 A critical review of the role of the major histocompatibility complex in fertilization, preimplantation development and feto-maternal interactions Hum Reprod Update 5 234 248 10438108 10.1093/humupd/5.3.234 1:CAS:528: DyaK1MXktlSjtrg%3D (Pubitemid 29271962)
15. JM Gardner AL Fletcher MS Anderson SJ Turley 2009 AIRE in the thymus and beyond Curr Opin Immunol 21 582 589 19833494 10.1016/j.coi.2009.08.007 1:CAS:528:DC%2BD1MXhsVKntb%2FI
16. T Lei S Jacob I Ajil-Zaraa JB Dubuisson O Irion, et al. 2007 Xeno-free derivation and culture of human embryonic stem cells: current status, problems and challenges Cell Res 17 682 688 17667917 10.1038/cr.2007.61 1:CAS:528:DC%2BD2sXovFeqtrw%3D (Pubitemid 47255938)
17. P Tangvoranuntakul P Gagneux S Diaz M Bardor N Varki, et al. 2003 Human uptake and incorporation of an immunogenic nonhuman dietary sialic acid Proc Natl Acad Sci USA 100 12045 12050 14523234 10.1073/pnas.2131556100 1:CAS:528:DC%2BD3sXotlGltbs%3D (Pubitemid 37271512)
18. HH Chou H Takematsu S Diaz J Iber E Nickerson, et al. 1998 A mutation in human CMP-sialic acid hydroxylase occurred after the Homo-Pan divergence Proc Natl Acad Sci USA 95 11751 11756 9751737 10.1073/pnas.95.20.11751 1:CAS:528:DyaK1cXmsV2hs74%3D (Pubitemid 28460486)
19. C Cerdan SC Bendall L Wang M Stewart T Werbowetski, et al. 2006 Complement targeting of nonhuman sialic acid does not mediate cell death of human embryonic stem cells Nat Med 12 1113 1114 17024197 10.1038/nm1006-1113 1:CAS:528:DC%2BD28XhtVChsr3F author reply 1115 (Pubitemid 44527337)
20. TE Ludwig ME Levenstein JM Jones WT Berggren ER Mitchen, et al. 2006 Derivation of human embryonic stem cells in defined conditions Nat Biotechnol 24 185 187 16388305 10.1038/nbt1177 1:CAS:528:DC%2BD28XhtFGqsrg%3D (Pubitemid 43221701)
21. BS Mallon KY Park KG Chen RS Hamilton RD McKay 2006 Toward xeno-free culture of human embryonic stem cells Int J Biochem Cell Biol 38 1063 1075 16469522 10.1016/j.biocel.2005.12.014 1:CAS:528:DC%2BD28XjtFags70%3D
22. C Xu MS Inokuma J Denham K Golds P Kundu, et al. 2001 Feeder-free growth of undifferentiated human embryonic stem cells Nat Biotechnol 19 971 974 11581665 10.1038/nbt1001-971 1:CAS:528:DC%2BD3MXntl2msbY%3D (Pubitemid 32947578)
23. AB Prowse MR Doran JJ Cooper-White F Chong TP Munro, et al. 2010 Long term culture of human embryonic stem cells on recombinant vitronectin in ascorbate free media Biomaterials 31 8281 8288 20674971 10.1016/j.biomaterials. 2010.07.037 1:CAS:528:DC%2BC3cXhtFWntLnP
24. K Rajala H Hakala S Panula S Aivio H Pihlajamaki, et al. 2007 Testing of nine different xeno-free culture media for human embryonic stem cell cultures Hum Reprod 22 1231 1238 17251355 10.1093/humrep/del523 1:CAS:528: DC%2BD2sXntlWmsr0%3D (Pubitemid 47062789)
25. N Lefort M Feyeux C Bas O Feraud A Bennaceur-Griscelli, et al. 2008 Human embryonic stem cells reveal recurrent genomic instability at 20q11.21 Nat Biotechnol 26 1364 1366 19029913 10.1038/nbt.1509 1:CAS:528:DC%2BD1cXhsVWjtLzI
26. TE Werbowetski-Ogilvie M Bosse M Stewart A Schnerch V Ramos-Mejia, et al. 2009 Characterization of human embryonic stem cells with features of neoplastic progression Nat Biotechnol 27 91 97 19122652 10.1038/nbt.1516 1:CAS:528:DC%2BD1MXhtVyjsg%3D%3D
27. D Herszfeld E Wolvetang E Langton-Bunker TL Chung AA Filipczyk, et al. 2006 CD30 is a survival factor and a biomarker for transformed human pluripotent stem cells Nat Biotechnol 24 351 357 16501577 10.1038/nbt1197 1:CAS:528:DC%2BD28XitFGis70%3D (Pubitemid 43372160)
28. A Al-Shamkhani 2004 The role of CD30 in the pathogenesis of haematopoietic malignancies Curr Opin Pharmacol 4 355 359 15251128 10.1016/j.coph.2004.02.007 1:CAS:528:DC%2BD2cXls1Wgu7w%3D (Pubitemid 38987061)
29. K Kim A Doi B Wen K Ng R Zhao, et al. 2010 Epigenetic memory in induced pluripotent stem cells Nature 467 285 290 20644535 10.1038/nature09342 1:CAS:528:DC%2BC3cXhtFOht7rJ
30. O Adewumi B Aflatoonian L Ahrlund-Richter M Amit PW Andrews, et al. 2007 Characterization of human embryonic stem cell lines by the International Stem Cell Initiative Nat Biotechnol 25 803 816 17572666 10.1038/nbt1318 1:CAS:528:DC%2BD2sXnsFaru7w%3D (Pubitemid 47052190)
31. JC Moore S Sadowy M Alikani AJ Toro-Ramos MR Swerdel, et al. 2010 A high-resolution molecular-based panel of assays for identification and characterization of human embryonic stem cell lines Stem Cell Res 4 92 106 20060795 10.1016/j.scr.2009.11.001 1:CAS:528:DC%2BC3cXnvFWgsr8%3D
32. V Akopian PW Andrews S Beil N Benvenisty J Brehm, et al. 2010 Comparison of defined culture systems for feeder cell free propagation of human embryonic stem cells In Vitro Cell Dev Biol Anim 46 247 258 20186512 10.1007/s11626-010- 9297-z
33. International Stem Cell Banking Initiative 2009 Consensus guidance for banking and supply of human embryonic stem cell lines for research purposes Stem Cell Rev 5 301 314 10.1007/s12015-009-9085-x
34. B Suarez-Alvarez RM Rodriguez V Calvanese MA Blanco-Gelaz ST Suhr, et al. 2010 Epigenetic mechanisms regulate MHC and antigen processing molecules in human embryonic and induced pluripotent stem cells PLoS ONE 5 e10192 20419139 10.1371/journal.pone.0010192
35. MT Sprinks MH Sellens GB Dealtry N Fernandez 1993 Preimplantation mouse embryos express Mhc class I genes before the first cleavage division Immunogenetics 38 35 40 8462992 10.1007/BF00216388 1:CAS:528:DyaK3sXkt1Kmsbg%3D (Pubitemid 23098601)
36. JC Cooper N Fernandez E Joly GB Dealtry 1998 Regulation of major histocompatibility complex and TAP gene products in preimplantation mouse stage embryos Am J Reprod Immunol 40 165 171 9764360 10.1111/j.1600-0897.1998.tb00408. x 1:STN:280:DyaK1cvjs1ymsw%3D%3D (Pubitemid 28380117)
37. M Drukker H Katchman G Katz S Even-Tov Friedman E Shezen, et al. 2006 Human embryonic stem cells and their differentiated derivatives are less susceptible to immune rejection than adult cells Stem Cells 24 221 229 16109762 10.1634/stemcells.2005-0188 (Pubitemid 44464789)
38. PW Lampton RJ Crooker JA Newmark CM Warner 2008 Expression of major histocompatibility complex class I proteins and their antigen processing chaperones in mouse embryonic stem cells from fertilized and parthenogenetic embryos Tissue Antigens 72 448 457 18778324 10.1111/j.1399-0039.2008.01132.x 1:CAS:528:DC%2BD1cXhsVCmsbbL
39. M Mammolenti S Gajavelli P Tsoulfas R Levy 2004 Absence of major histocompatibility complex class I on neural stem cells does not permit natural killer cell killing and prevents recognition by alloreactive cytotoxic T lymphocytes in vitro Stem Cells 22 1101 1110 15536199 10.1634/stemcells.22-6- 1101 1:CAS:528:DC%2BD2cXhtFShsr7O (Pubitemid 39507095)
40. DC Wu AS Boyd KJ Wood 2008 Embryonic stem cells and their differentiated derivatives have a fragile immune privilege but still represent novel targets of immune attack Stem Cells 26 1939 1950 18535153 10.1634/stemcells.2008-0078
41. AS Boyd KJ Wood 2009 Variation in MHC expression between undifferentiated mouse ES cells and ES cell-derived insulin-producing cell clusters Transplantation 87 1300 1304 19424028 10.1097/TP.0b013e3181a19421 1:CAS:528:DC%2BD1MXlsFKru7w%3D
42. R Dressel K Guan J Nolte L Elsner S Monecke, et al. 2009 Multipotent adult germ-line stem cells, like other pluripotent stem cells, can be killed by cytotoxic T lymphocytes despite low expression of major histocompatibility complex class I molecules Biol Direct 4 31 19715575 10.1186/1745-6150-4-31
43. NJ Robertson FA Brook RL Gardner SP Cobbold H Waldmann, et al. 2007 Embryonic stem cell-derived tissues are immunogenic but their inherent immune privilege promotes the induction of tolerance Proc Natl Acad Sci USA 104 20920 20925 18093946 10.1073/pnas.0710265105 1:CAS:528:DC%2BD1cXktlGisw%3D%3D
44. RJ Swijnenburg S Schrepfer JA Govaert F Cao K Ransohoff, et al. 2008 Immunosuppressive therapy mitigates immunological rejection of human embryonic stem cell xenografts Proc Natl Acad Sci USA 105 12991 12996 18728188 10.1073/pnas.0805802105 1:CAS:528:DC%2BD1cXhtFSmtrnK
45. BL Yen CJ Chang KJ Liu YC Chen HI Hu, et al. 2009 Brief report-human embryonic stem cell-derived mesenchymal progenitors possess strong immunosuppressive effects toward natural killer cells as well as T lymphocytes Stem Cells 27 451 456 18988708 10.1634/stemcells.2008-0390
46. KO Lui AS Boyd SP Cobbold H Waldmann PJ Fairchild 2010 A role for regulatory T cells in acceptance of ESC-derived tissues transplanted across an major histocompatibility complex barrier Stem Cells 28 10 1905 1914 20737577 10.1002/stem.506 1:CAS:528:DC%2BC3cXhsFKntbrE
47. KH Grinnemo R Genead M Kumagai-Braesch A Andersson C Danielsson, et al. 2008 Costimulation blockade induces tolerance to HESC transplanted to the testis and induces regulatory T-cells to HESC transplanted into the heart Stem Cells 26 1850 1857 18467659 10.1634/stemcells.2008.0111
48. VR Aluvihare M Kallikourdis AG Betz 2004 Regulatory T-cells mediate maternal tolerance to the fetus Nat Immunol 5 266 271 14758358 10.1038/ni1037 1:CAS:528:DC%2BD2cXhsFeitL8%3D (Pubitemid 38332123)
49. J Trowsdale AG Betz 2006 Mother's little helpers: mechanisms of maternal-fetal tolerance Nat Immunol 7 241 246 16482172 10.1038/ni1317 1:CAS:528:DC%2BD28XhsVSrs7g%3D
50. Y Sasaki M Sakai S Miyazaki S Higuma A Shiozaki, et al. 2004 Decidual and peripheral blood CD4 + CD25+ regulatory T-cells in early pregnancy subjects and spontaneous abortion cases Mol Hum Reprod 10 347 353 14997000 10.1093/molehr/gah044 1:STN:280:DC%2BD2c7pslOkug%3D%3D (Pubitemid 38714366)
51. LD Shultz Y Saito Y Najima S Tanaka T Ochi, et al. 2010 Generation of functional human T-cell subsets with HLA-restricted immune responses in HLA class I expressing NOD/SCID/IL2r gamma(null) humanized mice Proc Natl Acad Sci USA 107 13022 13027 20615947 10.1073/pnas.1000475107 1:CAS:528: DC%2BC3cXpsVCrsb8%3D
52. T Nitta S Murata T Ueno K Tanaka Y Takahama 2008 Thymic microenvironments for T-cell repertoire formation Adv Immunol 99 59 94 19117532 10.1016/S0065-2776(08)00603-2 1:CAS:528:DC%2BD1MXpsFeisro%3D
53. BF Haynes CS Heinly 1995 Early human T-cell development: analysis of the human thymus at the time of initial entry of hematopoietic stem cells into the fetal thymic microenvironment J Exp Med 181 1445 1458 7699329 10.1084/jem.181.4.1445 1:CAS:528:DyaK2MXkslWnt7k%3D
54. P Res H Spits 1999 Developmental stages in the human thymus Semin Immunol 11 39 46 9952357 10.1006/smim.1998.0152 1:STN:280:DyaK1M7jslOksw%3D%3D (Pubitemid 29083982)
55. K Nagano Y Yoshida T Isobe 2008 Cell surface biomarkers of embryonic stem cells Proteomics 8 4025 4035 18763704 10.1002/pmic.200800073 1:CAS:528:DC%2BD1cXht1KgtbfL
56. WM Schopperle WC DeWolf 2007 The TRA-1-60 and TRA-1-81 human pluripotent stem cell markers are expressed on podocalyxin in embryonal carcinoma Stem Cells 25 723 730 17124010 10.1634/stemcells.2005-0597 1:CAS:528:DC%2BD2sXktlehu7c%3D (Pubitemid 46354232)
57. SN Brimble ES Sherrer EW Uhl E Wang S Kelly, et al. 2007 The cell surface glycosphingolipids SSEA-3 and SSEA-4 are not essential for human ESC pluripotency Stem Cells 25 54 62 17008424 10.1634/stemcells.2006-0232 1:CAS:528:DC%2BD2sXhvVGjsbc%3D (Pubitemid 46052974)
58. Y Li H Zeng RH Xu B Liu Z Li 2009 Vaccination with human pluripotent stem cells generates a broad spectrum of immunological and clinical responses against colon cancer Stem Cells 27 3103 3111 19816950 1:CAS:528: DC%2BC3cXhsVCqt7c%3D
59. S Siegel A Wagner D Kabelitz M Marget J Coggin Jr, et al. 2003 Induction of cytotoxic T-cell responses against the oncofetal antigen-immature laminin receptor for the treatment of hematologic malignancies Blood 102 4416 4423 12869512 10.1182/blood-2003-01-0198 1:CAS:528:DC%2BD3sXpslGrsLk%3D (Pubitemid 37494105)
60. C Zelle-Rieser AL Barsoum F Sallusto R Ramoner JW Rohrer, et al. 2001 Expression and immunogenicity of oncofetal antigen-immature laminin receptor in human renal cell carcinoma J Urol 165 1705 1709 11342960 10.1016/S0022-5347(05) 66398-7 1:CAS:528:DC%2BD3MXjvVaitbY%3D (Pubitemid 32410293)
61. NE Tchabo P Mhawech-Fauceglia OL Caballero J Villella AF Beck, et al. 2009 Expression and serum immunoreactivity of developmentally restricted differentiation antigens in epithelial ovarian cancer Cancer Immun 9 6 19705800
62. W Dong J Du H Shen D Gao Z Li, et al. 2010 Administration of embryonic stem cells generates effective antitumor immunity in mice with minor and heavy tumor load Cancer Immunol Immunother 59 1697 1705 20683592 10.1007/s00262-010- 0899-9
63. LP Frenzel Z Abdullah AK Kriegeskorte R Dieterich N Lange, et al. 2009 Role of natural-killer group 2 member D ligands and intercellular adhesion molecule 1 in natural killer cell-mediated lysis of murine embryonic stem cells and embryonic stem cell-derived cardiomyocytes Stem Cells 27 307 316 18988711 10.1634/stemcells.2008-0528 1:CAS:528:DC%2BD1MXjslSjsbs%3D
64. O Preynat-Seauve C de Rham D Tirefort S Ferrari-Lacraz KH Krause, et al. 2009 Neural progenitors derived from human embryonic stem cells are targeted by allogeneic T and natural killer cells J Cell Mol Med 13 3556 3569 19320778 10.1111/j.1582-4934.2009.00746.x
65. R Dressel J Schindehutte T Kuhlmann L Elsner P Novota, et al. 2008 The tumorigenicity of mouse embryonic stem cells and in vitro differentiated neuronal cells is controlled by the recipients' immune response PLoS ONE 3 e2622 18612432 10.1371/journal.pone.0002622
66. R Dressel J Nolte L Elsner P Novota K Guan, et al. 2010 Pluripotent stem cells are highly susceptible targets for syngeneic, allogeneic, and xenogeneic natural killer cells FASEB J 24 7 2164 2177 20145206 10.1096/fj.09-134957 1:CAS:528:DC%2BC3cXptV2kt7Y%3D
67. JF Magliocca IK Held JS Odorico 2006 Undifferentiated murine embryonic stem cells cannot induce portal tolerance but may possess immune privilege secondary to reduced major histocompatibility complex antigen expression Stem Cells Dev 15 707 717 17105406 10.1089/scd.2006.15.707 1:CAS:528: DC%2BD28XhtF2ns7nL (Pubitemid 44748606)
68. WM Yokoyama S Kim 2006 How do natural killer cells find self to achieve tolerance? Immunity 24 249 257 16546094 10.1016/j.immuni.2006.03.006 1:CAS:528:DC%2BD28XjtlKms7c%3D
69. MT Orr LL Lanier 2010 Natural killer cell education and tolerance Cell 142 847 856 20850008 10.1016/j.cell.2010.08.031 1:CAS:528:DC%2BC3cXhtFyitb%2FP
70. AH Jonsson WM Yokoyama 2009 Natural killer cell tolerance licensing and other mechanisms Adv Immunol 101 27 79 19231592 10.1016/S0065-2776(08)01002-X 1:CAS:528:DC%2BD1MXpsFGmtLc%3D
71. L Li ML Baroja A Majumdar K Chadwick A Rouleau, et al. 2004 Human embryonic stem cells possess immune-privileged properties Stem Cells 22 448 456 15277692 10.1634/stemcells.22-4-448 1:CAS:528:DC%2BD2cXps1Kns74%3D (Pubitemid 39014562)
72. S Guller L LaChapelle 1999 The role of placental Fas ligand in maintaining immune privilege at maternal-fetal interfaces Semin Reprod Endocrinol 17 39 44 10406074 10.1055/s-2007-1016210 1:STN:280: DyaK1MzjsVGktw%3D%3D (Pubitemid 29293551)
73. N Yachimovich-Cohen S Even-Ram Y Shufaro J Rachmilewitz B Reubinoff 2010 Human embryonic stem cells suppress T-cell responses via arginase I-dependent mechanism J Immunol 184 1300 1308 20032293 10.4049/jimmunol.0804261 1:CAS:528:DC%2BC3cXhtVGisbw%3D
74. CA Koch P Geraldes JL Platt 2008 Immunosuppression by embryonic stem cells Stem Cells 26 89 98 17962705 10.1634/stemcells.2007-0151 1:CAS:528:DC%2BD1cXhvVCktL4%3D
75. WL Trigona CM Porter JA Horvath-Arcidiacono AS Majumdar ET Bloom 2007 Could heme-oxygenase-1 have a role in modulating the recipient immune response to embryonic stem cells? Antioxid Redox Signal 9 751 756 17511591 10.1089/ars.2007.1602 1:CAS:528:DC%2BD2sXlsVOqs7g%3D (Pubitemid 46799108)
76. V Bronte P Zanovello 2005 Regulation of immune responses by L-arginine metabolism Nat Rev Immunol 5 641 654 16056256 10.1038/nri1668 1:CAS:528:DC%2BD2MXmvVClsLc%3D (Pubitemid 41113195)
77. T Ishikawa T Harada H Koi T Kubota H Azuma, et al. 2007 Identification of arginase in human placental villi Placenta 28 133 138 16720041 10.1016/j.placenta.2006.03.015 1:CAS:528:DC%2BD2sXhsl2rug%3D%3D (Pubitemid 44914534)
78. P Kropf D Baud SE Marshall M Munder A Mosley, et al. 2007 Arginase activity mediates reversible T-cell hyporesponsiveness in human pregnancy Eur J Immunol 37 935 945 17330821 10.1002/eji.200636542 1:CAS:528:DC%2BD2sXkvVSgs7Y%3D (Pubitemid 46925331)
79. F Fandrich X Lin GX Chai M Schulze D Ganten, et al. 2002 Preimplantation-stage stem cells induce long-term allogeneic graft acceptance without supplementary host conditioning Nat Med 8 171 178 11821902 10.1038/nm0202-171 1:CAS:528:DC%2BD38Xht1equ7o%3D (Pubitemid 34155129)
80. D Fabricius S Bonde N Zavazava 2005 Induction of stable mixed chimerism by embryonic stem cells requires functional Fas/FasL engagement Transplantation 79 1040 1044 15880040 10.1097/01.TP.0000159142.62535.37 1:CAS:528: DC%2BD2MXjvF2ht74%3D (Pubitemid 40663994)
81. S Bonde N Zavazava 2006 Immunogenicity and engraftment of mouse embryonic stem cells in allogeneic recipients Stem Cells 24 2192 2201 16794265 10.1634/stemcells.2006-0022 1:CAS:528:DC%2BD2sXhtVWnsbg%3D (Pubitemid 44527472)
82. JS Hunt D Vassmer TA Ferguson L Miller 1997 Fas ligand is positioned in mouse uterus and placenta to prevent trafficking of activated leukocytes between the mother and the conceptus J Immunol 158 4122 4128 9126971 1:CAS:528:DyaK2sXivVCgsbw%3D (Pubitemid 127483910)
83. G Brunlid J Pruszak B Holmes O Isacson KC Sonntag 2007 Immature and neurally differentiated mouse embryonic stem cells do not express a functional Fas/Fas ligand system Stem Cells 25 2551 2558 17615270 10.1634/stemcells.2006- 0745 1:CAS:528:DC%2BD2sXht1CltLzM (Pubitemid 47582747)
84. CM Kelly SV Precious C Scherf R Penketh NN Amso, et al. 2009 Neonatal desensitization allows long-term survival of neural xenotransplants without immunosuppression Nat Methods 6 271 273 19270699 10.1038/nmeth.1308 1:CAS:528:DC%2BD1MXivVKks74%3D
85. P Matzinger T Kamala 2011 Tissue-based class control: the other side of tolerance Nat Rev Immunol 11 221 230 21350581 10.1038/nri2940 1:CAS:528:DC%2BC3MXisVOnsrk%3D
86. TA Ferguson TS Griffith 2006 A vision of cell death: Fas ligand and immune privilege 10 years later Immunol Rev 213 228 238 16972907 10.1111/j.1600-065X.2006.00430.x 1:CAS:528:DC%2BD28XhtF2lsrfP (Pubitemid 44401504)
87. B Engelhardt C Coisne 2011 Fluids and barriers of the CNS establish immune privilege by confining immune surveillance to a two-walled castle moat surrounding the CNS castle Fluids Barriers CNS 8 4 21349152 10.1186/2045-8118-8- 4
88. JA Thomson J Itskovitz-Eldor SS Shapiro MA Waknitz JJ Swiergiel, et al. 1998 Embryonic stem cell lines derived from human blastocysts Science 282 1145 1147 9804556 10.1126/science.282.5391.1145 1:CAS:528:DyaK1cXntleisLg%3D (Pubitemid 28516247)